Sensori-motor and Perceptual Functions of the PPC. (PPCfonctions)

January 16, 2026 updated by: Hospices Civils de Lyon

Sensori-motor and Perceptual Functions of the Posterior Parietal Cortex (PPC) in Patients With Optic Ataxia (AO) and Healthy Subjects.

To produce hand's movement directed towards a target, the investigator must combine several sensory information, such as vision or proprioception. The posterior parietal cortex (PPC) is a region of the cortex involved in this multisensory integration. A lesion of the PPC cause a visuo-motor trouble called optic ataxia but these patients also have perceptual troubles.

The aim of the study is to understand the different functions of the PPC and especially how the processes of spatial coding of the sensory information influences perception and motor planning.

In this study, the investigator want to explore the sensory motor and the perceptual performance of patients with optic ataxia compared with healthy subjects, using 6 behavioral tests.

Objectify the consequences of PPC impairment (visual-motor and perceptual consequences) on patients' quality of life and autonomy.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Bron, France, 69500
        • Recruiting
        • U1028 INSERM - CNRS UMR 5292 Equipe ImpAct
        • Contact:
        • Principal Investigator:
          • Laure Pisella, PhD
        • Sub-Investigator:
          • Sophie JACQUIN-COURTOIS, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

All patients and healthy subjects:

  • male and female, age from 18 to 75 years included
  • normal vision or corrected vision
  • covered by social security
  • signed written informed consent

Patients:

  • neurological injury in posterior parietal cortex supported by a cerebral MRI
  • present optic ataxia symptoms Healthy subjects
  • no known neurological injury

Exclusion Criteria:

- unable to comply with the tasks (neurological, psychiatric, sensory or motor troubles)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experience 1
In the experiences 1 and 2, the participant needs to point different visual targets (LED) in the dark.
Experimental: Experience 2
In the experiences 1 and 2, the participant needs to point different visual targets (LED) in the dark.
Experimental: Experience 3
In the experience 3, a tactile stimulation is applied to the middle finger of the 2 hands. The participant needs to indicate into a microphone when he feels the stimulation.
Experimental: Experience 4
Target dots or visual images are presented on a computer screen. The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.
Experimental: Experience 5
Target dots or visual images are presented on a computer screen. The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.
Experimental: Experience 6
Target dots or visual images are presented on a computer screen. The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
response error - number of pointing error
Time Frame: Day 0 after each stimulation
Day 0 after each stimulation
response error -measure of reaction times
Time Frame: Day 0 after each stimulation
Day 0 after each stimulation
response error - percentage of right responses
Time Frame: Day 0 after each stimulation
Day 0 after each stimulation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laure PISELLA, PhD, INSERM U1028 - Impact - CRNL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 22, 2018

Primary Completion (Estimated)

February 22, 2031

Study Completion (Estimated)

February 22, 2031

Study Registration Dates

First Submitted

September 14, 2017

First Submitted That Met QC Criteria

September 14, 2017

First Posted (Actual)

September 18, 2017

Study Record Updates

Last Update Posted (Actual)

January 20, 2026

Last Update Submitted That Met QC Criteria

January 16, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on point targets

Subscribe